FT Global Pharmaceutical and Biotechnology Conference

Thriving Amid Uncertainty

The 35th annual FT Global Pharmaceutical and Biotechnology Conference brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry, and the business models and transformation strategies that will be needed to survive and thrive in this new era of unprecedented disruption and uncertainty.

As a lead sponsor, ICON is pleased to offer clients and other third parties, a 25% discount of the registration fee – a saving of £474 off the full registration price of £1,899.

Simply complete the short form to receive your discount code.

Key Speakers include:

Steve Cutler
Chief Executive Officer, ICON Plc

Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017 having previously served as Chief Operating Officer from January 2014 to March 2017. Dr. Cutler served as Group President, Clinical Research Services from November 2011 until his appointment as Chief Operating Officer. 

Dr. Colin Orford
Senior Vice President, Drug Development Services, ICON Plc

Dr. Colin Orford is ICON’s Senior Vice President, Drug Development Services, where he is focused on developing new models of drug development which range in scope from virtual development with small companies through to externalized development for large pharma.

Kemal Malik
Member of the Board of Management, Bayer

Belén Garijo 
Member of the Board and CEO, Healthcare, Merck

Jeremy Levin
Chairman and CEO, Ovid Therapeutics; Former CEO, Teva Pharmaceuticals

Ameet Nathwani 
Executive Vice President, Group Chief Medical Officer, Sanofi